Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02055053 · ClinicalTrials.gov registry record · Phase 4
Effects of Local Anesthesia on Post-operative Pain During Laparoscopic Inguinal Hernia Repair
A Phase 4 study, sponsored by Lahey Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
NCT02055053 is a Phase 4 study that has completed, run by Lahey Clinic. The registered enrollment target is 70 participants.
The verdict
NCT02055053, a Phase 4 study, has completed, sponsored by Lahey Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
Study Summary
To assess effect of local anesthetic into the preperitoneal space during laparoscopic hernia repair on post-operative pain.
Interventions
- DRUG 0.5% Bupivicaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2013-08 |
| Est. Completion | 2019-10-16 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02055053
The ClinicalTrials.gov registry entry for NCT02055053 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lahey Clinic, which has 43 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 0.5% Bupivicaine is the first listed.
NCT02055053 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02055053 about?
NCT02055053 is a clinical study titled "Effects of Local Anesthesia on Post-operative Pain During Laparoscopic Inguinal Hernia Repair". To assess effect of local anesthetic into the preperitoneal space during laparoscopic hernia repair on post-operative pain.
What is the current status of trial NCT02055053?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2013-08. Estimated completion is 2019-10-16.
What interventions are being tested in trial NCT02055053?
The interventions under investigation include: 0.5% Bupivicaine (DRUG).
Who is sponsoring clinical trial NCT02055053?
This trial is sponsored by Lahey Clinic, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.